SCHEMBL4932009

SCHEMBL4932009

COc1ccc(-n2c(CCC(N)C(=O)NO)nc3cc(C)c(C)cc32)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 4/20 0.41
▸ ALDH1A1 P00352 4/20 0.41
▸ HPGD P15428 3/20 0.41
▸ HSD17B10 Q99714 3/20 0.41
▸ NPC1 O15118 3/20 0.41
▸ RAB9A P51151 3/20 0.41
▸ SMN1; SMN2 Q16637 3/20 0.41
▸ PDE10A Q9Y233 6/20 0.41
▸ DHFR P00374 1/20 0.41
▸ BACE1 P56817 1/20 0.40
▸ TP53 P04637 2/20 0.39
▸ DCTPP1 Q9H773 1/20 0.39
▸ GAA P10253 3/20 0.39
▸ MAPT P10636 2/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ MEN1 O00255 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ MGAM O43451 1/20 0.39
▸ AMY1A P0DUB6 1/20 0.39
▸ SI P14410 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4931996 1.00 KDM4E (0.41) KDM4EALDH1A1HPGDHSD17B10NPC1
SCHEMBL4936237 0.90 NTRK1 (0.41) KDM4EALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL4935414 0.90 NTRK1 (0.41) KDM4EALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL4935437 0.90 NTRK1 (0.41) KDM4EALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL4934374 0.88 HDAC6 (0.37) KDM4ENPC1RAB9ASMN1; SMN2PDE10A
SCHEMBL4934387 0.88 HDAC6 (0.37) KDM4ENPC1RAB9ASMN1; SMN2PDE10A
SCHEMBL4932064 0.88 NTRK1 (0.44) HSD17B10NPC1PDE10ATP53MEN1
SCHEMBL4933134 0.88 NTRK1 (0.44) HSD17B10NPC1PDE10ATP53MEN1
SCHEMBL4932046 0.88 NTRK1 (0.44) HSD17B10NPC1PDE10ATP53MEN1
SCHEMBL4927005 0.84 DCTPP1 (0.55) TP53DCTPP1MAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080132539-A1 Hydroxamic Acid Derivative And Age Generation Inhibitor Containing The Derivative KUREHA CORPORATION (JP) 2008-06-05 — — US disclosed
EP-1707560-A1 HYDROXAMIC ACID DERIVATIVE AND AGE GENERATION INHIBITOR CONTAINING THE DERIVATIVE Kureha Corporation (JP) 2006-10-04 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080132539-A1 Hydroxamic Acid Derivative And Age Generation Inhibitor Containing The Derivative HDAC5, HDAC1, HDAC9 KDM4E 480/4885ALDH1A1 1829/4885HPGD 65/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback